Pulmonary vascular diseases affect blood circulation in the lungs and pulmonary hypertension can lead to damage of the heart. These diseases can cause severe breathlessness and limit your ability to live an active life.
Our pulmonary hypertension program is one of the first and largest programs of its kind in the United States. Our physicians and nurse practitioners have extensive experience in diagnosing, evaluating and treating pulmonary vascular disease, including pulmonary hypertension.
Pulmonary vascular disorders include:
- Pulmonary arterial hypertension
- Pulmonary hypertension (associated with lung disease and/or hypoxemia)
- Pulmonary venous hypertension (associated with congestive heart failure or valvular disease)
- Acute and chronic thromboembolic disease
- Hepatopulmonary syndrome
Improving Quality of Life for People with High Blood Pressure in the Lungs
The Pulmonary Hypertension/Pulmonary Vascular Disease Program at Penn offers the most effective treatments available to slow the progression of pulmonary hypertension and even reverse some of the damage to the lungs and heart.
Pulmonary hypertension is type of high blood presue that affects the lungs, typically caused by common heart and lung diseases like congestive heart failure (CHF) or emphysema. Pulmonary hypertension due to disease in the blood vessels of the lungs, such as pulmonary arterial hypertension (PAH), is rarer. Until recently, patients with pulmonary hypertension, especially PAH, had very few options for the management of their disease. Today, we are at the forefront of research and patient care, offering revolutionary options to treat and manage pulmonary hypertension.
In This Section
Find out what our progam offers, and how we can help you find the treatment you need
Penn cardiologists provide advanced therapies for pulmonary hypertension.